Cargando…

S215: KEYNOTE-667: OPEN-LABEL, PHASE 2 STUDY OF PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (CHL) WITH SLOW EARLY RESPONSE TO FRONT-LINE CHEMOTHERAPY

Detalles Bibliográficos
Autores principales:	Vinti, Luciana, Daw, Stephen, Alvarez, Constantino Sabado, Fagioli, Franca, Beishuizen, Auke, Michel, Gerard, Moleti, Maria Luisa, Cepelova, Michaela, Thorwarth, Anne, Rigaud, Charlotte, de Sabando, Diego Plaza Lopez, Landman-Parker, Judith, Shen, Juan, Pillai, Pallavi, Marinello, Patricia, Mauz-Koerholz, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Oral Sessions
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428420/ http://dx.doi.org/10.1097/01.HS9.0000967772.35060.76

Ejemplares similares